Zipline™ aims to optimize clot removal efficiency, ultimately improving procedural success rates and patient outcomes. The FDA clearance marks a significant step forward in Perfuze’s mission ...
Medtech Perfuze has raised €22m. With the infusion, the company will release its catheters to select stroke centres in the US.
Zipline aims to optimize clot removal efficiency, ultimately improving procedural success rates and patient outcomes. The FDA clearance marks a significant step forward in Perfuze's mission to ...
By providing increased support and navigational ease, Zipline™ aims to optimize clot removal efficiency, ultimately improving procedural success rates and patient outcomes. The FDA clearance marks a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results